Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan
Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan
复制标题
DOI：
10.3109/00016489.2010.526142
复制
发表时间：
2011-03-01
影响因子：
1.4
通讯作者：
Shigeno, Koichiro
中科院分区：
文献类型：
--
作者：
Shojaku, Hideo;Watanabe, Yukio;Shigeno, Koichiro
结论：Meniett装置是一种微创、安全的治疗方法，可用于长期缓解延迟性内淋巴积水(DEH)和梅尼埃病(MD)患者的前庭症状。目的：根据1995年AAO-HNS标准评价Meniett装置对确诊为MD或DEH的患者的疗效。方法：对28例(29耳)MD和5例(5耳)DEH患者(同侧型4耳，对侧型1耳)采用日本中耳加压治疗研究组的Meniett装置进行治疗。在压力治疗之前，所有患者对包括利尿剂在内的药物治疗都没有反应。结果：16名MD患者(57%)和全部5名DEH患者(100%)完全没有眩晕发作；9名MD患者(32%)眩晕发作频率显著减少。听力方面，25耳(74%：MD，n=21；同侧DEH，n=4)听力水平稳定，仅4耳(12%：MD，n=3；对侧DEH，n=1)听力明显改善。没有并发症可归因于Meniett设备。
Conclusion: The Meniett device is a minimally invasive and safe treatment that may be used to provide longer-term reduction of vestibular symptoms in patients with delayed endolymphatic hydrops (DEH) as well as those with Meniere's disease (MD). Objective: The effects of the Meniett device were evaluated in patients with a diagnosis of definite MD or DEH according to the 1995 AAO-HNS criteria. Methods: Twenty-nine ears of 28 patients with MD and 5 ears of 5 patients with DEH (ipsilateral type 4, contralateral type 1) were treated with the Meniett device by the Middle Ear Pressure Treatment Research Group of Japan. All of the patients had failed to respond to medical treatment including diuretics before the pressure treatment. Results: Sixteen (57%) patients with MD and all five (100%) patients with DEH remained entirely free from vertigo spells; nine (32%) patients with MD responded with a significant decrease in the frequency of vertigo spells. In regard to hearing, 25 ears (74%: MD, n = 21; ipsilateral DEH, n = 4) had stable hearing levels; only 4 ears (12%: MD, n = 3; contralateral DEH, n = 1) showed a significant hearing improvement. No complications were attributable to the Meniett device.